Agreed, but in this case its more likely the irrational following of trading emotion on Hot Copper rather than the rational analysis of data.
OCC just announced a massive increase in sales that vastly out stripped their own forecasts. You have some excellent analysis above, particularly from @JonesingPanda on the most impressive and the most informative Appendix 4C to date by a country mile and a subdued response on here to dynamic figures, and accordingly a limited move on the stock.
Finally everyone gets what most have been bemoaning or ages, a lack of sales data. This report is crammed of impressive and informative sales data, but instead of insightful discussion of the large sales rises, pertinent to their investment, many investors above want to continue to gaze at their navels about the share price. It becomes self fulfilling, in exactly the opposite way big houses like Goldman's make money. They do analysis of a company, relatively unknown, see a little fairy dust in the business, do a nice pretty DCF analysis that most lay investors can't and release it to their millions of followers...hey presto they buy in numbers, the stock goes up and the analysis and company geniuses.
Similarly people come on here and start negatively bemoaning past trading patterns, rather than discussing new data, and the pattern becomes self-fulfilling as other investors read and lose focus on the data and fret about other investors selling and share price performance. Its why so many small caps 'fill the gap'. Hot Copper investors love talking about it and it becomes self fulfilling by their talk encouraging such actions.
Fact: OCC increased its BH Striate sales by 1300% from 1Q to 4Q and its much higher priced Remplir DVT sales by 96% across the same period.
@Hotdog11 I am reluctant to antagonise you as a large shareholder , but saying "0-15 million shares trading hands on announcement days, 38 cent at that time to 99 cents the highest our share price had ever been, investors made up to 130% profits" is misleading. It was more like 1.5million shares following the announcement that caused that move as the trading data below indicates (volumes in end column; open; daily high; daily low; close in the others.). The time when OCC traded volumes like you are talking about was in fact its May 2019 announcement of CelGro Nerve results in the subsequent table, as high as 70 million shares, but the stock more diluted by a few capital rises by then (that these figures dispel any future need of, contrary to comments above).
The May 2019 trading data:
That was an acute euphoric misunderstanding in the market of what OCC was doing in CelGro Nerve (Remplir) on the commercial pathway potential in 2019:
Now granted the markets are utterly irrational on so many levels, @Hotdog11's slightly misquoted trading recollection, an example in kind, but come on people? OCC is finally FDA/EMA/TGA approved and has just showed you at last meaningful sales data that cement its path to positive cash flows and the commercial success that it promised for so long and didn't deliver on - it now is in solid and irrefutable global Striate sales figures via Bio Horizon, and Remplir Aussie sales figures on the very product that drove the all time $0.99 highs that is actually in the Aussie mkt selling. And we know irrefutably, its listed at a $1,354 PBS price. I am not a business analysis by profession (an options trader), but come on people, throw some exploratory figures in a spreadsheet as Jonesing has done, or at least look at the 4C report.
Euphoric/pessimistic misinformed information can send share prices silly, but solid sales data makes businesses sustainable. OCC just showed that and will clarify on that in forth coming earnings, when the market will likely slowly pick up on the news, rather than take off on a dramatic euphoric run that doesn't benefit long-term holders, only frustrates them.
Lets rationally focus on the Appendix 4C data guys, which is packed with information compared to the normal slim offerings. There is a separate thread to discuss and bemoan share trading.
OCC Price at posting:
38.5¢ Sentiment: Buy Disclosure: Held
(20min delay)